WEDNESDAY, OCTOBER 7, 2020 @ 11:00 AM – 12:30 PM EDT Drug development in neuromuscular disorders needs robust biomarker and clinical endpoints to study drug…
Corporate
AMRA Medical’s Study on MRI-Based Muscle Composition in Diabetes Selected for EASD 2020
AMRA Medical assessed prevalence of sarcopenia, adverse muscle composition, and low functional performance within Type 2 Diabetes and will present at EASD…
AMRA Medical Will Highlight MRI-Based Muscle Composition in Obesity at ECOICO 2020
AMRA Medical assessed adverse muscle composition within obesity and its impact on functional performance and metabolic comorbidity and will digitally present the…
AMRA Researchers Make the Case for MRI Biomarkers for Neuromuscular Diseases
[Click on the image to view the summary video] Publication in Annals of Neurology describes the utility and implementation of MRI biomarkers…
AMRA Medical Will Present a Study on MRI-Based Body Composition in Liver Disease at The Digital International Liver Congress 2020
AMRA Medical and Linköping University collaborated on a liver biopsy-controlled MRI-based body composition study and will present the results at the congress….
AMRA Medical and the National University of Singapore Partner to Study NAFLD in Asia
AMRA will include a larger range of ethnicities in its global reference database of muscle and fat biomarkers to better characterize NAFLD….